Piperafizines A and B, potentiators of cytotoxicity of vincristine.
Kamei
H
H
Bristol-Myers Research Institute, Ltd., Tokyo Research Center, Japan.
Oka
M
M
Hamagishi
Y
Y
Tomita
K
K
Konishi
M
M
Oki
T
T
D000818:Animals; D000900:Anti-Bacterial Agents / Q000096:biosynthesis / Q000737:chemistry / Q000302:isolation & purification / Q000627:therapeutic use*; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005285:Fermentation; D006801:Humans; D007941:Leukemia P388 / Q000188:drug therapy*; D051379:Mice; D010879:Piperazines / Q000737:chemistry / Q000302:isolation & purification / Q000627:therapeutic use; D012988:Soil Microbiology; D013306:Streptomycetaceae / Q000145:classification / Q000378:metabolism*; D014407:Tumor Cells, Cultured; D014750:Vincristine / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D010879:Piperazines; C066103:piperafizine A; D014750:Vincristine; C066104:piperafizine B